Veterinary Medicines

Fasifree 10% w/v Oral Suspension

Authorised
  • Triclabendazole
Download as PDF

Product identification

Medicine name:
Fasifree 10% w/v Oral Suspension
Active substance:
  • Triclabendazole
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        56
        day
      • Milk
        48
        hour
    • Sheep
      • Meat and offal
        55
        day
      • Milk
        1
        year
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 1 litre high density polyethylene flat bottom back pack containers containing a white to off-white smooth suspension. The closures used for all pack sizes are 38 mm polypropylene standard caps with an induction heat seal liner. A 38 mm polypropylene spouted cap is also provided with each pack size for dispensing purposes.
  • 2.5 litre high density polyethylene flat bottom back pack containers containing a white to off-white smooth suspension. The closures used for all pack sizes are 38 mm polypropylene standard caps with an induction heat seal liner. A 38 mm polypropylene spouted cap is also provided with each pack size for dispensing purposes.
  • 5 litre high density polyethylene flat bottom back pack containers containing a white to off-white smooth suspension. The closures used for all pack sizes are 38 mm polypropylene standard caps with an induction heat seal liner. A 38 mm polypropylene spouted cap is also provided with each pack size for dispensing purposes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bimeda Animal Health Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22033/020/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."